← Eichor
Study identifier: NCT07710391 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

3D Printed Reverse Twin Block for Class III Malocclusion

Condition: Class III Malocclusion  ·  Sponsor: University of Baghdad

PhaseNA
Planned participants30
Who can joinAll sexes, 8 Years to 13 Years
Healthy volunteersNo

About this study

This RCT aims to evaluate the effectiveness of a novel 3D printed reverse twin block appliance in the management of maxillary deficiency in growing patients having class III malocclusion. The clinical outcomes of this appliance will be compared with the conventional reverse twin block appliance over 6 months treatment period. primary objective is evaluating of the effectiveness of 3DRTB in correcting sagittal discrepancies due to maxillary deficiency in class III malocclusion compared to conventional one while secondary objectives are assessment of transverse and vertical jaw relationship produced by 3DRTB compared to CRTB and to evaluate the soft tissue profile of class III patients and to evaluate the maxillary and mandibular incisor inclination, also assessment of patient perception with both appliances by using questionnaire and finally to assess the impact of 3DRTB on oral health compared to CRTB by using oral hygiene index.

This description comes directly from the study's public registry record.

Talk to the study team

Linda Basim, PhD  ·  +9647812867005  ·  landa.hadi2403@codental.uobaghdad.edu.iq

Always discuss trial participation with your own doctor first.

Locations (1)

Collage of Dentistry, University of BaghdadBaghdad, IraqRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07710391